Helix BioPharma Corp. (HBP.TO)
1.58
+0.01
(+0.64%)
CAD |
TSX |
May 15, 16:00
Helix BioPharma Debt to Equity Ratio : 0.0234 for Jan. 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Resverlogix Corp. | -0.8194 |
| Microbix Biosystems, Inc. | 0.2703 |
| COSCIENS Biopharma, Inc. | 0.1321 |
| Aptose Biosciences, Inc. | -0.9874 |
| Atlas Energy Corp. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 18.52M |
| Total Liabilities (Quarterly) | 3.164M |
| Shareholders Equity (Quarterly) | 15.36M |
| Current Ratio | 0.0427 |
| Net Debt Paydown Yield | -0.05% |